Lupin announced that it has received tentative approval from the United States Food and Drug Administration (FDA) under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Dolutegravir, Emtricitabine and Tenofovir Alafenamide (DETAF) Tablets.
This product would be manufactured at Lupin's Nagpur facility in India. DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- & middle-income countries.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
